
中东和非洲细胞外基质市场预测至 2028 年 - COVID-19 按原材料(牛、猪和其他原材料)、应用(软组织修复、硬脑膜修复、伤口愈合、心脏修复、心包修复、和血管修复与重建)
No. of Pages: 119 | Report Code: TIPRE00027063 | Category: Life Sciences
No. of Pages: 119 | Report Code: TIPRE00027063 | Category: Life Sciences
市场介绍
由蛋白质和其他分子组成的大型网络,围绕、支持和赋予体内细胞和组织结构。细胞外基质帮助细胞附着到附近的细胞并与其通信,并在细胞生长、细胞运动和其他细胞功能中发挥重要作用。细胞外基质还参与修复受损组织。细胞外基质的异常变化可能导致某些疾病的发生,例如癌症。
此外,外伤和心血管疾病的发生率增加以及血管重建手术的增加。然而,脱细胞细胞外基质使用过程中的挑战预计将限制预测期内的市场增长。
大流行增加了对医疗器械的需求,这些器械可用于-家庭护理。该地区入住重症监护病房 (ICU) 的患者数量不断增加,药物数量不断增加,给紧张的卫生系统带来多重诊断和治疗挑战,导致医疗设备增加。员工分配和工作时间发生了变化,并实施了严格的感染控制和社交距离措施。此外,他们还面临精神、身体、情感和经济方面的挑战。 COVID-19目前没有任何特效的抗病毒药物治疗,因此对该病的治疗主要集中在对症治疗和氧疗上。建议在整个疾病过程中监测炎症因子和淋巴细胞亚群。目前中东和非洲地区重症和危重症COVID-19患者的治疗是控制死亡人数不断上升的关键。政府目前正在开展多项工作来发现、重新利用和/或开发 COVID-19 的预防和治疗方案。撒哈拉以南非洲地区制药业发展欠佳,无法有效满足该地区对COVID-19生物医学管理的防治需求。
市场概况和动态
中东和非洲细胞外基质预计到 2028 年,该市场将从 2021 年的 1,485.2 万美元增至 2,278.4 万美元。从 2021 年到 2028 年,该市场预计将以 6.3% 的复合年增长率增长。再生医学促进受影响区域组织再生的潜力减少了组织移植的需求。细胞外基质来源于现成的组织来源,它可以刺激体内组织生长,炎症最小,并且是现成的。细胞外基质的这些优点使得理想的软组织替代治疗程序能够修复轮廓缺陷。预计血管重建或整形手术的增加将在预测期内增加细胞外基质。
主要细分市场
就原材料而言,2020年,猪在中东和非洲细胞外基质市场中占据最大份额。从应用来看,2020年软组织修复领域占据了中东和非洲细胞外基质市场的最大份额。
主要来源和上市公司
在准备这份关于中东细胞外基质市场的报告时提到的一些主要的一手和二手来源东非地区包括公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括美敦力 (Medtronic)、默克 (Merck Kgaa)、施乐辉 (Smith & Nephew)、康乐保集团 (Coloplast Group)、百特 (Baxter)、帝斯曼 (DSM) 和库克生物科技 (Cook Biotech)。
购买报告的理由
中东和非洲细胞外基质市场细分
强>
按原料
按应用
< span>按国家/地区
提及的公司
Strategic insights for Middle East and Africa Extracellular Matrix involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,485.2 thousand |
Market Size by 2028 | US$ 2,278.4 thousand |
Global CAGR (2021 - 2028) | 6.3% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 原料
|
Regions and Countries Covered | 中东和非洲
|
Market leaders and key company profiles |
The regional scope of Middle East and Africa Extracellular Matrix refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Extracellular Matrix Market is valued at US$ 1,485.2 thousand in 2021, it is projected to reach US$ 2,278.4 thousand by 2028.
As per our report Middle East and Africa Extracellular Matrix Market, the market size is valued at US$ 1,485.2 thousand in 2021, projecting it to reach US$ 2,278.4 thousand by 2028. This translates to a CAGR of approximately 6.3% during the forecast period.
The Middle East and Africa Extracellular Matrix Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Extracellular Matrix Market report:
The Middle East and Africa Extracellular Matrix Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Extracellular Matrix Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Extracellular Matrix Market value chain can benefit from the information contained in a comprehensive market report.